tiprankstipranks
DR Horton (DHI)
NYSE:DHI
Want to see DHI full AI Analyst Report?

DR Horton (DHI) AI Stock Analysis

2,856 Followers

Top Page

DHI

DR Horton

(NYSE:DHI)

Select Model
Select Model
Select Model
Neutral 67 (OpenAI - 5.2)
Rating:67Neutral
Price Target:
$156.00
▲(6.30% Upside)
Action:Reiterated
Date:07/22/26
The score is driven mainly by solid underlying financial strength (healthy profitability and conservative leverage) and a supportive valuation (13.52 P/E with a 1.22% yield). Offsetting these positives, technical indicators show a clear downtrend (price below all major moving averages, negative MACD, weak RSI), and the earnings call highlighted meaningful near-term demand pressure (higher cancellations and elevated incentives) despite strong margin execution and shareholder returns.
Positive Factors
High Profitability & Margin Execution
Consistently strong gross and pre-tax margins demonstrate durable execution and pricing power in homebuilding. Higher-than-guidance margins and TTM net margins (~9.5%) indicate core earnings resilience that can sustain profitability even if volumes moderate, supporting long‑term cash generation and returns.
Negative Factors
Rising Cancellation Rate
A 20% cancellation rate materially reduces expected closings and erodes near-term revenue and cash flow predictability. Persistently higher cancellations reflect buyer qualification and affordability stress that can suppress realized volumes and increase carrying, marketing and incentive costs over multiple quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
High Profitability & Margin Execution
Consistently strong gross and pre-tax margins demonstrate durable execution and pricing power in homebuilding. Higher-than-guidance margins and TTM net margins (~9.5%) indicate core earnings resilience that can sustain profitability even if volumes moderate, supporting long‑term cash generation and returns.
Read all positive factors

DR Horton Key Performance Indicators (KPIs)

Any
Any
Income Before Taxes by Segment
Income Before Taxes by Segment
Shows the profitability of each business segment before tax, highlighting which areas are driving earnings and which may need strategic adjustments.
Chart InsightsHomebuilding pre-tax income has come down from the 2022 cycle peak but a sequential rebound in Q2 2026 suggests margins are holding up as construction cost savings and disciplined pricing offset softer demand; Forestar, Financial Services and Rental remain smaller, volatile contributors. Management is deliberately trimming deliveries to protect margins while returning cash via buybacks/dividends and maintaining strong liquidity—future upside hinges on continued cost reductions and lower cancellations, whereas lot‑cost inflation and elevated incentives pose the main downside risk.
Data provided by:The Fly

DR Horton (DHI) vs. SPDR S&P 500 ETF (SPY)

DR Horton Business Overview & Revenue Model

Company Description
Established in Arlington, Texas, in 1978, D.R. Horton, Inc. operates as a prominent residential construction enterprise. The company's core business involves acquiring and preparing land, then constructing and marketing homes across a substantial ...
How the Company Makes Money
D.R. Horton primarily makes money by selling newly constructed homes to individual buyers. Revenue is recognized from homebuilding when homes are delivered/closed, and the company’s earnings in this core business are driven by (1) the number of ho...

DR Horton Earnings Call Summary

Earnings Call Date:Jul 21, 2026
(Q3-2026)
|
% Change Since: |
Next Earnings Date:Oct 29, 2026
Earnings Call Sentiment Positive
The call conveyed operational strength—notably margin outperformance, strong cash generation, disciplined capital returns, and cost reductions—while also acknowledging demand softness, a higher cancellation rate, elevated incentives, rising SG&A from footprint expansion, and some lot-cost inflation. Management emphasized nimble, returns-focused operating decisions (trimming full-year deliveries, holding margin) and maintained robust liquidity and buyback/dividend plans. Overall, positive execution on profitability and capital allocation is tempered by near-term demand and cost pressures.
Positive Updates
Strong Profitability and Margins
Consolidated pre-tax income of $1.2 billion on $9.2 billion of revenues, delivering a pre-tax profit margin of 13.3%. Home sales gross margin of 20.7%, above the high end of guidance.
Negative Updates
EPS and Revenue Pressure Year-over-Year
EPS declined to $3.20 from $3.36 in the prior-year quarter (down ~4.8%). Home sales revenue down ~3% year-over-year; average closing price down 2% YoY to $362,000.
Read all updates
Q3-2026 Updates
Negative
Strong Profitability and Margins
Consolidated pre-tax income of $1.2 billion on $9.2 billion of revenues, delivering a pre-tax profit margin of 13.3%. Home sales gross margin of 20.7%, above the high end of guidance.
Read all positive updates
Company Guidance
Management guided fourth-quarter consolidated revenues of $8.8–$9.3 billion, homebuilding closings of 22,500–23,000 homes, a home‑sales gross margin of 20.5%–21.0% and a consolidated pre‑tax profit margin of 12.3%–12.8%; for full‑year fiscal 2026 they now expect consolidated revenues of about $32.5–$33.0 billion, 83,800–84,300 homes closed, an income tax rate of ~25%, at least $3.0 billion of operating cash flow, roughly $2.5 billion of share repurchases and about $500 million of dividends; they also said Q4 starts will be lower than Q3, rental inventory should remain around $3.0 billion, and noted June 30 liquidity of $6.1 billion (including $2.1 billion cash and $4.0 billion available credit), total debt of $7.1 billion and consolidated leverage of 23% (long‑term target ~20%).

DR Horton Financial Statement Overview

Summary
Overall financials remain solid for a cyclical homebuilder: profitability is still healthy (TTM net margin ~9.5%) and leverage is conservative (debt-to-equity ~0.25–0.28). However, results have clearly normalized from the 2022–2023 peak with margin compression, essentially flat TTM revenue, and choppier cash-flow momentum (more volatile operating/free cash flow despite FCF ~0.96x net income).
Income Statement
72
Positive
Balance Sheet
78
Positive
Cash Flow
67
Positive
BreakdownTTMSep 2025Sep 2024Sep 2023Sep 2022Sep 2021
Income Statement
Total Revenue33.35B34.25B36.80B35.46B33.48B27.77B
Gross Profit7.54B8.12B9.54B9.35B10.50B7.88B
EBITDA4.11B4.84B6.37B6.41B7.71B5.43B
Net Income3.05B3.59B4.76B4.75B5.86B4.18B
Balance Sheet
Total Assets36.51B35.47B36.10B32.58B30.35B24.02B
Cash, Cash Equivalents and Short-Term Investments2.08B2.99B4.52B3.87B2.54B3.21B
Total Debt7.18B6.03B5.97B5.14B6.11B5.45B
Total Liabilities12.10B10.73B10.28B9.44B10.57B8.80B
Stockholders Equity23.82B24.19B25.31B22.70B19.40B14.89B
Cash Flow
Free Cash Flow3.31B3.28B2.02B4.16B413.60M267.00M
Operating Cash Flow3.35B3.42B2.19B4.30B561.80M534.40M
Investing Cash Flow-258.70M-168.70M-190.60M-310.20M-414.90M-252.20M
Financing Cash Flow-3.62B-4.76B-1.36B-2.67B-811.20M-85.10M

DR Horton Risk Analysis

DR Horton disclosed 26 risk factors in its most recent earnings report. DR Horton reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

DR Horton Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
$6.67B10.6410.85%-8.99%-22.26%
74
Outperform
$23.71B12.8714.73%0.78%-7.28%-26.86%
74
Outperform
$13.64B10.9515.49%0.68%3.62%-2.11%
72
Outperform
$16.59B15.1331.02%-9.30%-19.36%
69
Neutral
$19.79B12.897.36%2.36%-7.47%-47.15%
67
Neutral
$40.01B13.5912.77%1.19%-3.54%-15.86%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DHI
DR Horton
146.01
-6.05
-3.98%
LEN
Lennar
84.82
-32.33
-27.60%
NVR
NVR
6,304.81
-1,525.63
-19.48%
PHM
PulteGroup
129.55
9.84
8.22%
TOL
Toll Brothers
151.33
26.42
21.15%
TMHC
Taylor Morrison
72.45
8.13
12.64%

DR Horton Corporate Events

Private Placements and FinancingRegulatory Filings and Compliance
D.R. Horton Establishes New Direct Financial Obligation
Neutral
May 12, 2026
D.R. Horton disclosed that information previously provided under an item relating to entry into a material definitive agreement is being incorporated by reference into another item concerning the creation of a direct financial obligation or simila...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 22, 2026